Relating biopsy and clinical variables to radical prostatectomy findings: Can insignificant and advanced prostate cancer be predicted in a screening population?
- 30 September 2004
- journal article
- research article
- Published by Elsevier BV in Urology
- Vol. 64 (3), 544-550
- https://doi.org/10.1016/j.urology.2004.04.008
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- An Artificial Neural Network for Prostate Cancer Staging when Serum Prostate Specific Antigen is 10 NG./ML. or LessJournal of Urology, 2003
- Carcinoma Extent in Prostate Needle Biopsy Tissue in the Prediction of Whole Gland Tumor Volume in a Screening PopulationAmerican Journal of Clinical Pathology, 2002
- RELATIONSHIP BETWEEN SYSTEMATIC BIOPSIES AND HISTOLOGICAL FEATURES OF 222 RADICAL PROSTATECTOMY SPECIMENS: LACK OF PREDICTION OF TUMOR SIGNIFICANCE FOR MEN WITH NONPALPABLE PROSTATE CANCERJournal of Urology, 2001
- Prospective Evaluation of Men With Stage T1C Adenocarcinoma of the ProstateJournal of Urology, 1997
- Impalpable Invisible Stage T1c Prostate Cancer: Characteristics and Clinical Relevance in 100 Radical Prostatectomy Specimens-A Different ViewJournal of Urology, 1997
- Prospective characterization of pathological features of Prostatic Carcinomas Detected Via Serum Prostate Specific Antigen Based ScreeningJournal of Urology, 1996
- The Volume of Prostate Cancer in the Biopsy Specimen Cannot Reliably Predict the Quantity of Cancer in the Radical Prostatectomy Specimen on an Individual BasisJournal of Urology, 1995
- Identification of insignificantprostate cancers: Analysis of preoperative parametersUrology, 1994
- Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancerJAMA, 1994
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991